Table 8.
FDA-Approved Fluorinated Miscellaneous Drugs.
| Name | Structure | Therapeutic Uses | 
|---|---|---|
| Asciminib |   | Chronic-phase chronic myeloid leukemia (Ph+ CML) | 
| Atogepant |   | Episodic migraine headaches | 
| Avacopan |   | Granulomatosis polyangiitis (GPA) or microscopic polyangiitis | 
| Delafloxacin |   | Skin structural infections | 
| Elagolix |   | Endometriosis-related discomfort | 
| Enasidenib |   | Acute myeloid leukemia | 
| Lasmiditan |   | Acute migraine headaches with or without aura | 
| Lemborexant |   | Insomnia that interferes with falling asleep and/or staying asleep | 
| Lumateperone |   | Positive and negative symptoms in schizophrenia patients | 
| Melphalan flufenamide |   | Relapsed or resistant multiple myeloma | 
| Netupitant |   | Nausea and vomiting brought on by chemotherapy in addition to other medications | 
| Pimavanserin |   | Anti-psychotic drug | 
| Selinexor |   | Multiple myeloma | 
| Tafenoquine |   | Treatment and prevention of vivax malaria | 
| Upadacitinib |   | Moderate to severe forms of rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, and severe atopic dermatitis | 
| Ubrogepant |   | Acute migraines both with and without aura | 
| Vericiguat |   | Systolic heart failure. |